The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors - Sushi domains and the B1 family of G protein-coupled receptors

被引:39
作者
Perrin, Marilyn H.
Grace, Christy R. R.
Riek, Roland
Vale, Wylie W.
机构
[1] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA
[2] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA
来源
VIP, PACAP, AND RELATED PEPTIDES: FROM GENE TO THERAPY | 2006年 / 1070卷
关键词
D O I
10.1196/annals.1317.065
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The corticotropin-releasing factor (CRIT) receptors, CRF-R1 and CRF-R2, belong to the B1 subfamily of G protein-coupled Receptors (GPCRs), including receptors for secretin, growth hormone-releasing hormone (GHRH), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), calcitonin, parathyroid hormone (PTH), glucagon, and glucagon-like peptide-1 (GLP-1). The peptide ligand family comprises CRF, Uen 1, 2, and 3. CRF plays the major role in integrating the response to stress. Additionally, the ligands exhibit many effects on muscle, pancreas, heart, and the GI, reproductive, and immune systems. CRF-R1 has higher affinity for CRF than does CRF-R2 while both receptors bind Uen 1 equally. CRF-R2 shows specificity for Ucns 2 and 3. A major binding domain of the CRFRs is the N terminus/first extracellular domain (ECD1). Soluble proteins corresponding to the ECD1s of each receptor bind CRF ligands with nanomolar affinities. Our three-dimentional (3D) nuclear magnetic resonance (NMR) structure of a soluble protein corresponding to the ECD1 of CRF-R2 beta (1) identified its structural fold as a Sushi domain/short consensus repeat (SCR), stabilized by three disulfide bridges, two tryptophan residues, and an internal salt bridge (Asp65-Arg101). Disruption of the bridge by D65A mutation abrogates ligand recognition and results in loss ofthe well-defined disulfide pattern
引用
收藏
页码:105 / 119
页数:15
相关论文
共 55 条
[1]   Human CRF2 α and β splice variants:: pharmacological characterization using radioligand binding and a luciferase gene expression assay [J].
Ardati, A ;
Goetschy, V ;
Gottowick, J ;
Henriot, S ;
Valdenaire, O ;
Deuschle, U ;
Kilpatrick, GJ .
NEUROPHARMACOLOGY, 1999, 38 (03) :441-448
[2]   CRF and CRF receptors: Role in stress responsivity and other behaviors [J].
Bale, TL ;
Vale, WW .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2004, 44 :525-557
[3]   Structural analysis of the complement control protein (CCP) modules of GABAB receptor 1a -: Only one of the two CCP modules is compactly folded [J].
Blein, S ;
Ginham, R ;
Uhrin, D ;
Smith, BO ;
Soares, DC ;
Veltel, S ;
McIlhinney, RAJ ;
White, JH ;
Barlow, PN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (46) :48292-48306
[4]   Structure and distribution of modules in extracellular proteins [J].
Bork, P ;
Downing, AK ;
Kieffer, B ;
Campbell, ID .
QUARTERLY REVIEWS OF BIOPHYSICS, 1996, 29 (02) :119-167
[5]   Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway [J].
Brar, BK ;
Jonassen, AK ;
Stephanou, A ;
Santilli, G ;
Railson, J ;
Knight, RA ;
Yellon, DM ;
Latchman, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8508-8514
[6]   IDENTIFICATION OF A 7 TRANSMEMBRANE HELIX RECEPTOR FOR CORTICOTROPIN-RELEASING FACTOR AND SAUVAGINE IN MAMMALIAN BRAIN [J].
CHANG, CP ;
PEARSE, RV ;
OCONNELL, S ;
ROSENFELD, MG .
NEURON, 1993, 11 (06) :1187-1195
[7]   A soluble mouse brain splice variant of type 2α corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity [J].
Chen, AM ;
Perrin, MH ;
DiGruccio, MR ;
Vaughan, JM ;
Brar, BK ;
Arias, CM ;
Lewis, KA ;
Rivier, JE ;
Sawchenko, PE ;
Valet, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) :2620-2625
[8]   EXPRESSION CLONING OF A HUMAN CORTICOTROPIN-RELEASING-FACTOR RECEPTOR [J].
CHEN, RP ;
LEWIS, KA ;
PERRIN, MH ;
VALE, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8967-8971
[9]   Functional characterization of corticotropin-releasing factor type 1 receptor endogenously expressed in human embryonic kidney 293 cells [J].
Dautzenberg, FM ;
Higelin, J ;
Teichert, U .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 390 (1-2) :51-59
[10]   The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: Generation of chimeric receptors with a novel ligand-selective profile [J].
Dautzenberg, FM ;
Kilpatrick, GJ ;
Wille, S ;
Hauger, RL .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) :821-829